2.6.1.5	(4-hydroxyphenyl)acetic acid	74% inhibition with tyrosine at 3 mM and (4-hydroxyphenyl)acetic acid at 12 mM	10446	
2.6.1.5	2-aminooxyacetate	-	172051	
2.6.1.5	2-chloro-3-(5-{[(2,6-difluorobenzyl)oxy]methyl}-5-methyl-4,5-dihydro-1,2-oxazol-3-yl)-6-(propan-2-yl)pyridine	1 mM: 79% inhibition of enzyme activity, 0.5 mM: 67% inhibition of enzyme activity, 0.25 mM: 44% inhibition of enzyme activity	172050	
2.6.1.5	2-oxoglutarate	substrate inhibition at high concentration	34	
2.6.1.5	2-oxoglutarate	enzyme shows substrate inhibition	34	
2.6.1.5	3,4-dihydroxyphenylalanine	-	1782	
2.6.1.5	3,4-Dihydroxyphenyllactate	strong inhibition of all the three TAT isoenzymes	20609	
2.6.1.5	3-(3,4-Dihydroxyphenyl)-2-methylalanine	-	29458	
2.6.1.5	3-(5-{[(2,6-difluorobenzyl)oxy]methyl}-5-methyl-4,5-dihydro-1,2-oxazol-3-yl)pyridine-2-carbonitrile	1 mM: 82% inhibition of enzyme activity, 0.5 mM: 46% inhibition of enzyme activity, 0.25 mM: 8% inhibition of enzyme activity	172049	
2.6.1.5	3-methoxydopamine	-	91498	
2.6.1.5	3-Methoxytyrosine	-	43336	
2.6.1.5	4-methylsulfonyl-2,5,6,2',4',5'-hexachlorobiphenyl	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0008 mM	125167	
2.6.1.5	4-methylsulfonyl-2,5,6,2',4'-pentachlorobiphenyl	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0007 mM	125166	
2.6.1.5	5-hydroxyindole acetic acid	55% inhibition with tyrosine at 3 mM and 5-hydroxyindole acetic acid at 12 mM	43544	
2.6.1.5	5-hydroxytryptophan	30% inhibition with tyrosine at 3 mM and 5-hydroxytryptophan at 12 mM	2540	
2.6.1.5	Ag2+	-	1041	
2.6.1.5	AgNO3	10 mM, complete inhibition	360	
2.6.1.5	alpha-Methyl-L-aspartate	with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates	96130	
2.6.1.5	alpha-Methyltyrosine	-	43749	
2.6.1.5	Aminooxyacetate	probably acts reacting with the cofactor	1374	
2.6.1.5	Aminooxyacetate	1 mM, complete inhibition	1374	
2.6.1.5	beta-Methyl-L-aspartate	with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates	92777	
2.6.1.5	beta-phenylalanine	enzyme shows substrate inhibition	88728	
2.6.1.5	Ca2+	-	15	
2.6.1.5	Canaline	-	5532	
2.6.1.5	Canaline	probably acts reacting with the cofactor	5532	
2.6.1.5	cinmethylin	0.5 mM: 96% inhibition of enzyme activity, 0.25 mM: 20% inhibition of enzyme activity	172047	
2.6.1.5	CuSO4	10 mM, complete inhibition	263	
2.6.1.5	D-Aspartate	weak inhibition	634	
2.6.1.5	D-tyrosine	9% inhibition with tyrosine at 3 mM and D-tyrosine at 12 mM	1643	
2.6.1.5	Dextran sulfate	dextran sulfate inhibits TAT activity but conditioned macrophage medium reliably increases enzyme activity in hepatocytes	2775	
2.6.1.5	dihydroxymandelic acid	65% inhibition with tyrosine at 3 mM and dihydroxymandelic acid at 3 mM	93201	
2.6.1.5	dihydroxyphenylacetic acid	88% inhibition with tyrosine at 3 mM and dihydroxyphenylacetic acid at 3 mM	29946	
2.6.1.5	dopamine	100% inhibition with tyrosine at 3 mM and dopamine at 12 mM	242	
2.6.1.5	EDTA	1 mM, 21% residual activity	21	
2.6.1.5	Hg2+	-	33	
2.6.1.5	homogentisate	half-maximal inhibition with 15 micromolar	1826	
2.6.1.5	homovanillic acid	-	12554	
2.6.1.5	indole-3-acetic acid	42% inhibition with tyrosine at 3 mM and indole-3-acetic acid at 12 mM	2965	
2.6.1.5	indole-3-butyric acid	71% inhibition with tyrosine at 3 mM and indole-3-butyric acid at 12 mM	12559	
2.6.1.5	Indole-3-propionic acid	48% inhibition with tyrosine at 3 mM and indole-3-propionic acid at 12 mM	6537	
2.6.1.5	ketoconazole	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0011 mM	483	
2.6.1.5	kynuric acid	10 mM, complete inhibition	125165	
2.6.1.5	L-aspartate	with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates	97	
2.6.1.5	L-glutamate	-	41	
2.6.1.5	L-glutamate	competitive inhibition	41	
2.6.1.5	methiozolin	0.5 mM: 91% inhibition of enzyme activity, 0.25 mM: 57% inhibition of enzyme activity	172048	
2.6.1.5	Mn2+	-	11	
2.6.1.5	norepinephrine	competitive inhibition	975	
2.6.1.5	normetanephrine	-	7260	
2.6.1.5	phenylacetic acid	30% inhibition with tyrosine at 3 mM and phenylacetic acid at 12 mM	960	
2.6.1.5	Phenylethylamine	80% inhibition with tyrosine at 3 mM and phenylethylamine at 12 mM	900	
2.6.1.5	phenylhydrazine	1 mM, complete inhibition	398	
2.6.1.5	rosmarinic acid	isoenzymes TAT-2 and TAT-3	2035	
2.6.1.5	serotonin	37% inhibition with tyrosine at 3 mM and serotonin at 12 mM	437	
2.6.1.5	SnCl2	10 mM, complete inhibition	3228	
2.6.1.5	sodium dodecylsulfate	1 mM, complete inhibition	1066	
2.6.1.5	tolylfluanid	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0014 mM	125168	
2.6.1.5	tyramine	13% inhibition with tyrosine at 3 mM and tyramine at 12 mM	280	
2.6.1.5	Urea	the enzyme shows a gradual decrease in the activity till 2.5 M urea, after which the complete loss of activity is measured	116	
2.6.1.5	vanillylmandelic acid	51% inhibition with tyrosine at 3 mM and vanillylmandelic acid at 3 mM	30503	
2.6.1.5	Zn2+	-	14